The MOTS-c peptide, finally explained the way it should be.
A 16-amino-acid peptide encoded in mitochondrial DNA — studied for metabolism, insulin sensitivity, exercise capacity, and healthy aging. We translate every study into clear, sourced summaries. No hype, no influencers.
What is MOTS-c?
The mitochondrial-derived peptide explained — discovery, mechanism, and AMPK signaling.
Explore →What it may do
Metabolism, exercise capacity, insulin sensitivity, longevity — what the studies actually show.
Explore →Suppliers & guides
Research-grade peptide vendors, study library, dosing references, and safety guides.
Explore →A clinician-style review process, not a supplement blog.
Every page is built the same way: pull the primary literature, summarize the mechanism, flag what's preclinical vs. human, and link out to the source.
Source the primary literature
We start from PubMed, Cell Metabolism, Nature, and Aging — not Reddit threads or vendor pages.
Translate the mechanism
We explain AMPK signaling, mitochondrial biology, and study design in plain language anyone can audit.
Separate evidence from hype
Preclinical, observational, and clinical findings are clearly labeled. We never recommend a protocol.
Read the side-effect, dosing, and regulatory status guide before anything else.
MOTS-c is a 16-amino-acid peptide encoded by the 12S rRNA region of mitochondrial DNA. It is released into circulation and acts on skeletal muscle, adipose tissue, the liver, and bone — primarily through activation of AMPK, the cell's master energy sensor. Downstream, this drives glucose uptake, fatty-acid oxidation, and mitochondrial biogenesis, which is why MOTS-c is frequently described in the literature as an "exercise-mimetic" peptide.
Plasma MOTS-c declines with age and is lower in people with type 2 diabetes and obesity. Preclinical studies show it improves insulin sensitivity, prevents diet-induced obesity, restores exercise capacity in aged mice, and protects against bone and muscle loss. Human data are still mostly observational, and there is no FDA-approved MOTS-c product. Anyone considering it should review the safety and dosing page and work with a licensed clinician.
Who MOTS-c research matters to.
Metabolic health
Type 2 diabetes, insulin resistance, prediabetes, NAFLD.
Healthy aging
Sarcopenia, declining VO₂ max, frailty risk, healthspan.
Athletic performance
Endurance, mitochondrial density, recovery from training.
Bone health
Osteoporosis risk, age-related bone loss, post-menopausal.
What the people who study MOTS-c say.
"MOTS-c functions as a mitochondrial signal that regulates metabolic homeostasis and may serve as a therapeutic target for age-related diseases."
"MOTS-c is an exercise-induced regulator of muscle homeostasis and physical capacity in aged mice — restoring performance to that of young controls."
Get the MOTS-c research digest
One short email a month with new studies, takeaways, and protocols. No spam.
Frequently asked questions
01What is MOTS-c in simple terms?
MOTS-c is a small peptide encoded inside mitochondrial DNA. It acts as a signaling molecule that helps cells respond to stress, regulate energy, and improve glucose handling.
02Is MOTS-c approved by the FDA?
No. MOTS-c is currently a research peptide. It is not an approved drug or supplement, and any use outside a clinical trial is not regulated.
03Why is MOTS-c interesting for longevity?
MOTS-c levels decline with age, and animal studies show it improves metabolic health, insulin sensitivity, and physical performance — all hallmarks of healthy aging.
04How is MOTS-c different from a normal peptide hormone?
Most peptide hormones are encoded in nuclear DNA. MOTS-c is encoded inside mitochondrial DNA itself, which makes it part of a small family called mitochondrial-derived peptides (MDPs) and gives it a unique role in cell-to-cell metabolic signaling.
05What conditions is MOTS-c being studied for?
Active research areas include type 2 diabetes, obesity, NAFLD (fatty liver), sarcopenia, osteoporosis, age-related cardiovascular decline, and broader healthspan endpoints. Most data are still preclinical.
References
- Lee C., Zeng J., Drew B.G., et al. The mitochondrial-derived peptide MOTS-c promotes metabolic homeostasis and reduces obesity and insulin resistance. Cell Metabolism, 2015. View source →
- Reynolds J.C., Lai R.W., Woodhead J.S.T., et al. MOTS-c is an exercise-induced mitochondrial-encoded regulator of age-dependent physical decline and muscle homeostasis. Nature Communications, 2021. View source →
- Kim S.J., Mehta H.H., Wan J., et al. Naturally occurring mitochondrial-derived peptides are age-dependent regulators of apoptosis, insulin sensitivity, and inflammatory markers. Aging, 2018. View source →
Links open on PubMed or the original journal. Last reviewed dates reflect when our editorial team last verified each citation.